Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Supernus Pharmaceuticals, Inc. (SUPN)
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.supernus.com
Company Research
Source: Seeking Alpha
Company Participants Jack Khattar - Founder, President, CEO, Secretary & Director Timothy Dec - Senior VP & CFO Conference Call Participants Peter Vozzo John Cox - Jefferies LLC, Research Division David Amsellem - Piper Sandler & Co., Research Division Stacy Ku - TD Cowen, Research Division Kristen Kluska - Cantor Fitzgerald & Co., Research Division Pavan Patel - BofA Securities, Research Division Jack Padovano - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to hand the conference over to Peter Vozzo of ICR Healthcare, Investor Relations representative for Supernus Pharmaceuticals. You may now begin. Peter Vozzo Thank you, Antoine. Good afternoon, everyone, and thank you for joining us today for Supernus
Show less
Read more
Impact Snapshot
Event Time:
SUPN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SUPN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SUPN alerts
High impacting Supernus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SUPN
News
- Supernus Pharmaceuticals (SUPN) was given a new $65.00 price target by Craig Hallum.MarketBeat
- Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Supernus Pharmaceuticals's (NASDAQ:SUPN) Q4 CY2025: Strong Sales [Yahoo! Finance]Yahoo! Finance
- Supernus Announces Record Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Supernus Pharmaceuticals to Participate in March Investor Conferences [Yahoo! Finance]Yahoo! Finance
SUPN
Earnings
- 2/24/26 - Miss
SUPN
Analyst Actions
- 12/19/25 - Stifel
SUPN
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- SUPN's page on the SEC website